» Articles » PMID: 37231519

MSCs' Conditioned Media Cytokine and Growth Factor Profiles and Their Impact on Macrophage Polarization

Overview
Publisher Biomed Central
Date 2023 May 25
PMID 37231519
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is a growing body of evidence that multipotent mesenchymal stromal cells' (MSCs') remarkable therapeutic potential is attributed not only to their differentiation and regenerative capacity, but also to the paracrine effect, underlying their immunomodulatory properties. MSCs' secretome (i.e., cytokines, growth factors, and extracellular vesicles) is therefore increasingly discussed in the context of their ability to modulate inflammatory response and promote regeneration. There is evidence that 2D or 3D culturing conditions have an impact on the cells' secretome, and here we aimed to compare the secretion of cytokines and growth factors in human MSCs from different sources cultured in 2D and 3D conditions and assess their effect on human macrophages polarization in vitro.

Methods: MSCs were derived from human adipose tissue, bone marrow, gingiva, placenta, and umbilical cord, cultured as monolayers or as cell spheroids. Their cytokine profiles were analyzed, and data standardization was carried out using a z-score. Human peripheral blood mononuclear cells-derived macrophages were then treated with umbilical cord-derived MSCs' conditioned media and their effect on macrophages polarization was assessed.

Results: Our findings suggest that umbilical cord-derived MSCs' conditioned media demonstrated the highest cytokine and growth factor levels and despite mostly pro-inflammatory cytokine profile were able to promote anti-inflammatory macrophage polarization.

Conclusions: Umbilical cord-derived MSCs' conditioned media hold great potential for therapeutic use, demonstrating significant anti-inflammatory effect on human macrophages.

Citing Articles

Conditioned medium from human adipose-derived mesenchymal stem cells attenuates cardiac injury induced by Movento in male rats: role of oxidative stress and inflammation.

Zangiabadi I, Askaripour M, Rajizadeh M, Badreh F, Bagheri M, Jafari E BMC Pharmacol Toxicol. 2025; 26(1):13.

PMID: 39844289 PMC: 11753139. DOI: 10.1186/s40360-025-00847-w.


3D Culture of MSCs for Clinical Application.

Gao Q, Cekuc M, Ergul Y, Pius A, Shinohara I, Murayama M Bioengineering (Basel). 2025; 11(12.

PMID: 39768017 PMC: 11726872. DOI: 10.3390/bioengineering11121199.


Unlocking the Therapeutic Potential of Adipose-Derived Stem Cell Secretome in Oral and Maxillofacial Medicine: A Composition-Based Perspective.

Giannasi C, Cadelano F, Della Morte E, Baserga C, Mazzucato C, Niada S Biology (Basel). 2025; 13(12.

PMID: 39765683 PMC: 11673083. DOI: 10.3390/biology13121016.


Conditioned Medium Derived From Human Dental Follicle Mesenchymal Stem Cells Alleviates Macrophage Proinflammatory Responses Through MAPK-ERK-EGR1 Axis.

Zhang C, Lv P, Liang Q, Zhou J, Wu B, Xu W Stem Cells Int. 2024; 2024:5514771.

PMID: 39650749 PMC: 11623994. DOI: 10.1155/sci/5514771.


Mesenchymal stem cell application in pulmonary disease treatment with emphasis on their interaction with lung-resident immune cells.

Hazrati A, Mirarefin S, Malekpour K, Rahimi A, Khosrojerdi A, Rasouli A Front Immunol. 2024; 15:1469696.

PMID: 39582867 PMC: 11581898. DOI: 10.3389/fimmu.2024.1469696.


References
1.
He X, Dong Z, Cao Y, Wang H, Liu S, Liao L . MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing. Stem Cells Int. 2019; 2019:7132708. PMC: 6754952. DOI: 10.1155/2019/7132708. View

2.
Wang J, Xia J, Huang R, Hu Y, Fan J, Shu Q . Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization. Stem Cell Res Ther. 2020; 11(1):424. PMC: 7522905. DOI: 10.1186/s13287-020-01937-8. View

3.
Valeta-Magara A, Gadi A, Volta V, Walters B, Arju R, Giashuddin S . Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network. Cancer Res. 2019; 79(13):3360-3371. PMC: 7331114. DOI: 10.1158/0008-5472.CAN-17-2158. View

4.
Redondo-Castro E, Cunningham C, Miller J, Brown H, Allan S, Pinteaux E . Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming. Stem Cell Res Ther. 2018; 9(1):11. PMC: 5773162. DOI: 10.1186/s13287-017-0753-5. View

5.
Fierabracci A, Del Fattore A, Muraca M, Delfino D, Muraca M . The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease. Curr Drug Targets. 2015; 17(2):229-38. DOI: 10.2174/1389450116666150722140633. View